Barclays »

Mira Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Mira Pharmaceuticals (MIRA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mira Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mira Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $150 159 0.94

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Mira Pharmaceuticals

Vanguard Capital Management
Cross Staff Investments
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Captrust Financial Advisors
Northern Trust
First American Bank
Commonwealth Equity Services
State Street Corporation
International Assets Investment Management
Fifth Third Bancorp
Citadel Advisors
Susquehanna International
Mariner Wealth Advisors

View all funds holding Mira Pharmaceuticals